REFERENCES
2. Ahmed, S.; Amin, M. M.; Sayed, S. Ocular drug delivery: a comprehensive review. AAPS. PharmSciTech. 2023, 24, 66.
3. Khan, S.; Do, C. W.; Ho, E. A. Recent updates on drug delivery approaches for improved ocular delivery with an insight into nanostructured drug delivery carriers for anterior and posterior segment disorders. Drug. Deliv. Transl. Res. 2025, 15, 1828-76.
4. Han, H.; Li, S.; Xu, M.; et al. Polymer- and lipid-based nanocarriers for ocular drug delivery: current status and future perspectives. Adv. Drug. Delivery. Rev. 2023, 196, 114770.
5. Subrizi, A.; Del Amo, E. M.; Korzhikov-Vlakh, V.; Tennikova, T.; Ruponen, M.; Urtti, A. Design principles of ocular drug delivery systems: importance of drug payload, release rate, and material properties. Drug. Discov. Today. 2019, 24, 1446-57.
6. Onugwu, A. L.; Nwagwu, C. S.; Onugwu, O. S.; et al. Nanotechnology based drug delivery systems for the treatment of anterior segment eye diseases. J. Control. Release. 2023, 354, 465-88.
7. Bhandari, A. Ocular fluid mechanics and drug delivery: a review of mathematical and computational models. Pharm. Res. 2021, 38, 2003-33.
8. Wen, J. C.; Reina-Torres, E.; Sherwood, J. M.; et al. Intravitreal anti-VEGF injections reduce aqueous outflow facility in patients with neovascular age-related macular degeneration. Invest. Ophthalmol. Vis. Sci. 2017, 58, 1893-8.
9. Alshaikh, R. A.; Waeber, C.; Ryan, K. B. Polymer based sustained drug delivery to the ocular posterior segment: barriers and future opportunities for the treatment of neovascular pathologies. Adv. Drug. Delivery. Rev. 2022, 187, 114342.
10. Cerna-Chavez, R.; Rozanska, A.; Poretti, G. L.; Benvenisty, N.; Parulekar, M.; Lako, M. Retinal pigment epithelium exhibits gene expression and phagocytic activity alterations when exposed to retinoblastoma chemotherapeutics. Exp. Eye. Res. 2023, 233, 109542.
11. Kim, H.; Roh, H.; Kim, S. H.; Lee, K.; Im, M.; Oh, S. J. Effective protection of photoreceptors using an inflammation-responsive hydrogel to attenuate outer retinal degeneration. NPJ. Regen. Med. 2023, 8, 68.
12. Williams BK, J. R.; Di Nicola, M. Ocular oncology-primary and metastatic malignancies. Med. Clin. North. Am. 2021, 105, 531-50.
13. Nishath, T.; Stacey, A. W.; Steinberg, D.; et al. Global retinoblastoma study group. retinoblastoma survival and enucleation outcomes in 41 countries from the African continent. Br. J. Ophthalmol. 2024, 109, 64-9.
14. Yilmaz, M. T.; Sari, S. Y.; Zorlu, F.; Yazici, G. External beam radiotherapy in the management of uveal melanoma. Curr. Treat. Options. Oncol. 2024, 25, 932-51.
15. Kaliki, S.; Shields, C. L.; Rojanaporn, D.; et al. Scleral necrosis after plaque radiotherapy of uveal melanoma: a case-control study. Ophthalmology 2013, 120, 1004-11.
16. Kovács, G. SP-0035 The role of interstitial radiotherapy in orbital tumors or extrascleral uveal melanoma. Radiother. Oncol. 2021, 158, S21.
17. Shields, C. L.; Suribhatla, R.; Romero, M.; et al. Tissue glue-assisted plaque radiotherapy for choroidal tumors with scleral thinning. Retina 2025, 45, 675-82.
18. Grümme, L.; Biewald, E.; Reschke, M.; et al. Comparing efficacy and side effects of two systemic chemotherapy regimens for eye-preserving therapy in children with retinoblastoma. Pediatr. Blood. Cancer. 2022, 69, e29362.
19. Grzybowski, A.; Told, R.; Sacu, S.; et al. ; Euretina Board. 2018 Update on intravitreal injections: Euretina expert consensus recommendations. Ophthalmologica. 2018, 239, 181-93.
20. Biewald, E. M.; Bornfeld, N.; Metz, K. A.; et al. Histopathology of retinoblastoma eyes enucleated after intra-arterial chemotherapy. Br. J. Ophthalmol. 2020, 104, 1171-5.
21. Ramos, M. S.; Xu, L. T.; Singuri, S.; et al. Patient-reported complications after intravitreal injection and their predictive factors. Ophthalmol. Retina. 2021, 5, 625-32.
22. Da, M.; Li, K. K.; Chan, K. C.; Wu, E. X.; Wong, D. S. Distribution of triamcinolone acetonide after intravitreal injection into silicone oil-filled eye. Biomed. Res. Int. 2016, 2016, 5485467.
23. Kasiński, A.; Zielińska-Pisklak, M.; Oledzka, E.; Sobczak, M. Smart hydrogels - synthetic stimuli-responsive antitumor drug release systems. Int. J. Nanomedicine. 2020, 15, 4541-72.
24. Li, S.; Chen, L.; Fu, Y. Nanotechnology-based ocular drug delivery systems: recent advances and future prospects. J. Nanobiotechnol. 2023, 21, 232.
25. Rumon, M. M. H.; Akib, A. A.; Sarkar, S. D.; et al. Polysaccharide-based hydrogels for advanced biomedical engineering applications. ACS. Polym. Au. 2024, 4, 463-86.
26. Feng, Y.; Zhang, Z.; Tang, W.; Dai, Y. Gel/hydrogel-based in situ biomaterial platforms for cancer postoperative treatment and recovery. Exploration. (Beijing). 2023, 3, 20220173.
27. Yu, C.; Xu, J.; Heidari, G.; et al. Injectable hydrogels based on biopolymers for the treatment of ocular diseases. Int. J. Biol. Macromol. 2024, 269, 132086.
28. Shao, H.; Yin, K.; Xu, N.; et al. Adaptive surfaces with stimuli-responsive wettability: from tailoring to applications. ACS. Nano. 2025, 19, 6729-47.
29. Solanki, R.; Bhatia, D. Stimulus-responsive hydrogels for targeted cancer therapy. Gels 2024, 10, 440.
30. Sabbagh, F.; Zargarian, S. S.; Kosik-Kozioł, A.; Nakielski, P.; Pierini, F. Hydrogel-based ocular drug delivery systems. J. Mater. Chem. B. 2025, 13, 14982-5006.
31. Torres-Luna, C.; Fan, X.; Domszy, R.; Hu, N.; Wang, N. S.; Yang, A. Hydrogel-based ocular drug delivery systems for hydrophobic drugs. Eur. J. Pharm. Sci. 2020, 154, 105503.
32. Kalairaj, M. S.; Pradhan, R.; Saleem, W.; Smith, M. M.; Gaharwar, A. K. Intra-articular injectable biomaterials for cartilage repair and regeneration. Adv. Healthc. Mater. 2024, 13, e2303794.
33. Kaur, H.; Gogoi, B.; Sharma, I.; et al. Hydrogels as a potential biomaterial for multimodal therapeutic applications. Mol. Pharm. 2024, 21, 4827-48.
34. Lin, D.; Lei, L.; Shi, S.; Li, X. Stimulus-responsive hydrogel for ophthalmic drug delivery. Macromol. Biosci. 2019, 19, e1900001.
35. Khattak, S.; Ullah, I.; Sohail, M.; et al. Endogenous/exogenous stimuli‐responsive smart hydrogels for diabetic wound healing. Aggregate 2024, 6, e688.
36. Guo, L.; Fu, Z.; Li, H.; et al. Smart hydrogel: a new platform for cancer therapy. Adv. Colloid. Interface. Sci. 2025, 340, 103470.
37. Manjeri, A.; George, S. D. Hydrogel-embedded polydimethylsiloxane contact lens for ocular drug delivery. ACS. Appl. Bio. Mater. 2024, 7, 7324-31.
38. Chen, Y.; Yan, Y.; Wei, W. Research advances of matrix metalloproteinases family in uveal melanoma. Eur. J. Med. Res. 2025, 30, 609.
39. Cheng, X.; Xu, H. D.; Ran, H. H.; Liang, G.; Wu, F. G. Glutathione-depleting nanomedicines for synergistic cancer therapy. ACS. Nano. 2021, 15, 8039-68.
40. Luo, Z.; Wu, Q.; Yang, C.; et al. A powerful CD8+ T-Cell stimulating D-tetra-peptide hydrogel as a very promising vaccine adjuvant. Adv. Mater. 2017, 29.
41. Anemone, A.; Consolino, L.; Arena, F.; Capozza, M.; Longo, D. L. Imaging tumor acidosis: a survey of the available techniques for mapping in vivo tumor pH. Cancer. Metastasis. Rev. 2019, 38, 25-49.
42. Alizadeh, H.; Ahmadi, M.; Heydari Shayesteh, O. On chip synthesis of a pH sensitive gefitinib anticancer drug nanocarrier based on chitosan/alginate natural polymers. Sci. Rep. 2024, 14, 772.
43. Wang, Y.; Wang, J.; Yuan, Z.; et al. Chitosan cross-linked poly(acrylic acid) hydrogels: drug release control and mechanism. Colloids. Surf. B. Biointerfaces. 2017, 152, 252-9.
44. Fan, W.; Chen, M.; Raza, F.; et al. pH-sensitive peptide hydrogel encapsulating the anti-angiogenesis drug conbercept and chemotherapeutic drug dox as a combination therapy for retinoblastoma. Mater. Adv. 2024, 5, 2175-84.
45. Chu, S.; Shi, X.; Tian, Y.; Gao, F. pH-responsive polymer nanomaterials for tumor therapy. Front. Oncol. 2022, 12, 855019.
46. Peng, S.; Xiao, F.; Chen, M.; Gao, H. Tumor-microenvironment-responsive nanomedicine for enhanced cancer immunotherapy. Adv. Sci. (Weinh). 2022, 9, e2103836.
47. Zhang, J.; Su, L.; Liu, Z.; et al. A responsive hydrogel modulates innate immune cascade fibrosis to promote ocular surface reconstruction after chemical injury. J. Control. Release. 2024, 365, 1124-38.
48. Zhou, J.; Wang, H.; Chen, H.; et al. pH-responsive nanocomposite hydrogel for simultaneous prevention of postoperative adhesion and tumor recurrence. Acta. Biomater. 2023, 158, 228-38.
49. Zhu, J.; Zhang, X.; Ai, L.; Yuan, R.; Ye, J. Clinicohistopathological implications of MMP/VEGF expression in retinoblastoma: a combined meta-analysis and bioinformatics analysis. J. Transl. Med. 2019, 17, 226.
50. Cui, Q.; Wang, X.; Zhang, Y.; Shen, Y.; Qian, Y. Macrophage-derived MMP-9 and MMP-2 are closely related to the rupture of the fibrous capsule of hepatocellular carcinoma leading to tumor invasion. Biol. Proced. Online. 2023, 25, 8.
51. Sobczak, M. Enzyme-responsive hydrogels as potential drug delivery systems-state of knowledge and future prospects. Int. J. Mol. Sci. 2022, 23.
52. Zhang, Q.; Hu, W.; Guo, M.; et al. MMP-2 responsive peptide hydrogel-based nanoplatform for multimodal tumor therapy. Int. J. Nanomedicine. 2024, 19, 53-71.
53. Lee, S.; Hong, H. K.; Song, J. S.; et al. Intravitreal injectable hydrogel rods with long-acting bevacizumab delivery to the retina. Acta. Biomater. 2023, 171, 273-88.
54. Chen, L.; Yan, D.; Wu, N.; et al. Injectable bio-responsive hydrogel for therapy of inflammation related eyelid diseases. Bioact. Mater. 2021, 6, 3062-73.
55. Estrela, J. M.; Ortega, A.; Obrador, E. Glutathione in cancer biology and therapy. Crit. Rev. Clin. Lab. Sci. 2006, 43, 143-81.
56. Liu, H.; Deng, Z.; Li, T.; et al. Fabrication, GSH-responsive drug release, and anticancer properties of thioctic acid-based intelligent hydrogels. Colloids. Surf. B. Biointerfaces. 2022, 217, 112703.
57. Hsu, P. H.; Almutairi, A. Recent progress of redox-responsive polymeric nanomaterials for controlled release. J. Mater. Chem. B. 2021, 9, 2179-88.
58. Xu, Z.; Yang, W.; Zhang, R.; et al. Microenvironment-programmed siRNA-based hydrogel for spatiotemporal gene silencing in wound healing. Adv. Mater. 2025, 37, e09558.
59. Zhang, R.; Nie, T.; Fang, Y.; Huang, H.; Wu, J. Poly(disulfide)s: from synthesis to drug delivery. Biomacromolecules 2022, 23, 1-19.
60. Li, F.; Ding, J.; Li, Z.; Rong, Y.; He, C.; Chen, X. ROS-responsive thermosensitive polypeptide hydrogels for localized drug delivery and improved tumor chemoimmunotherapy. Biomater. Sci. 2024, 12, 3100-11.
61. Xu, H.; Cao, W.; Zhang, X. Selenium-containing polymers: promising biomaterials for controlled release and enzyme mimics. Acc. Chem. Res. 2013, 46, 1647-58.
62. Abed, H. F.; Abuwatfa, W. H.; Husseini, G. A. Redox-responsive drug delivery systems: a chemical perspective. Nanomaterials. (Basel). 2022, 12, 3183.
63. Zhou, J.; Fang, C.; Rong, C.; Luo, T.; Liu, J.; Zhang, K. Reactive oxygen species-sensitive materials: a promising strategy for regulating inflammation and favoring tissue regeneration. Smart. Mater. Med. 2023, 4, 427-46.
64. Mathew, J. Ru-hung, .; Le, T.; et al. ROS-responsive camptothecin-linked thioketal drug delivery system based on ring-closing polymerization. Eur. Polym. J. 2024, 202, 112646.
65. Yang, M.; Chen, X.; Chen, Z.; et al. Thermoresponsive antioxidant metal-free carbon nanodot hydrogel: An effective therapeutic approach for ocular surface disease. Sci. Adv. 2025, 11, eadt8775.
66. Chang, R.; Wang, X.; Li, X.; An, H.; Qin, J. Self-activated healable hydrogels with reversible temperature responsiveness. ACS. Appl. Mater. Interfaces. 2016, 8, 25544-51.
67. Tuszynska, M.; Skopinska-Wisniewska, J.; Bartniak, M.; Bajek, A. Conceptualization and preliminary characterization of poloxamer-based hydrogels for biomedical applications. Bioconjugate. Chem. 2025, 36, 1169-79.
68. Levin, M.; Cohen, N. Thermo-mechanics of PNIPAM gels: from a single chain to a network response. Macromolecules 2025, 58, 5187-200.
69. Kopač, T. Mathematical model for characterization of temperature-responsive polymers: A study on the rheological behavior of gelatin and poly(N-isopropylacrylamide). Polym. Test. 2024, 133, 108402.
70. Balan, G. A.; Precupas, A.; Matei, I. Gelation behaviour of Pluronic F127/polysaccharide systems revealed via thioflavin T fluorescence. Gels 2023, 9, 939.
71. Shriky, B.; Mahmoudi, N.; Kelly, A.; Isreb, M.; Gough, T. The effect of PEO homopolymers on the behaviours and structural evolution of Pluronic F127 smart hydrogels for controlled drug delivery systems. Colloids. Surf. A. Physicochem. Eng. Asp. 2022, 645, 128842.
72. Wang, Q.; Zhao, X.; Yu, F.; et al. Photocurable and temperature-sensitive bioadhesive hydrogels for sutureless sealing of full-thickness corneal wounds. Small. Methods. 2024, 8, e2300996.
73. Luo, J.; Zhao, X.; Guo, B.; Han, Y. Preparation, thermal response mechanisms and biomedical applications of thermosensitive hydrogels for drug delivery. Expert. Opin. Drug. Deliv. 2023, 20, 641-72.
74. Annala, A.; Sadeghi, A.; Toropainen, E.; et al. Intravitreal sustained release of dexamethasone from a self-healing injectable hydrogel: an in vivo safety and release study. Mol. Pharm. 2025, 22, 6920-31.
75. Luo, Z.; Jin, L.; Xu, L.; et al. Thermosensitive PEG-PCL-PEG (PECE) hydrogel as an in situ gelling system for ocular drug delivery of diclofenac sodium. Drug. Delivery. 2016, 23, 63-8.
76. Yang, C.; Liao, X.; Zhou, K.; et al. Multifunctional nanoparticles and collagenase dual loaded thermosensitive hydrogel system for enhanced tumor-penetration, reversed immune suppression and photodynamic-immunotherapy. Bioact. Mater. 2025, 48, 1-17.
77. Li, L.; Scheiger, J. M.; Levkin, P. A. Design and applications of photoresponsive hydrogels. Adv. Mater. 2019, 31, e1807333.
78. Zhao, Y.; Ran, B.; Lee, D.; Liao, J. Photo-controllable smart hydrogels for biomedical application: a review. Small. Methods. 2024, 8, e2301095.
79. Pandey, T.; Pandey, V. A mechanistic understanding to photophysical phenomenon in development of near-infrared (NIR) responsive hydrogels: advancements in precision drug delivery. J. Drug. Deliv. Sci. Technol. 2025, 106, 106682.
80. Xing, Y.; Zeng, B.; Yang, W. Light responsive hydrogels for controlled drug delivery. Front. Bioeng. Biotechnol. 2022, 10, 1075670.
81. Ansari, A.; Bhowmik, S.; Zhang, K.; et al. A visible light-responsive hydrogel to study the effect of dynamic tissue stiffness on cellular mechanosensing. Adv. Funct. Mater. 2025, 35, 2501585.
82. Hao, Z. W.; Zhang, Z. Y.; Wang, Z. P.; et al. Bioactive peptides and proteins for tissue repair: microenvironment modulation, rational delivery, and clinical potential. Mil. Med. Res. 2024, 11, 75.
83. Pal, K.; Singh, S.; Itakura, S.; Hashimoto, M.; Kusamori, K.; Nishikawa, M. Reactive oxygen species augmented polydopamine-chlorin e6 nanosystem for enhanced chemo/photothermal/photodynamic therapy: a synergistic trimodal combination approach in vitro & in vivo. Int. J. Biol. Macromol. 2024, 283, 137236.
84. Liao, S.; Yue, W.; Cai, S.; et al. Improvement of gold nanorods in photothermal therapy: recent progress and perspective. Front. Pharmacol. 2021, 12, 664123.
85. Shuai, C.; Pan, G.; He, T.; Shuai, X.; Wu, P.; Zhong, Q. Photothermal effect of graphene oxide accelerate singlet oxygen release from artesunate to endow the scaffold with antibacterial properties. Mater. Today. Commun. 2024, 39, 109058.
86. Kumar, R.; Singh, S. K.; Srivastava, R. K.; Mallick, S.; Vankayala, R. NIR-responsive black phosphorus nanosheet-integrated niosomes for combinatorial chemo-phototherapy of cancers. ACS. Bio. Med. Chem. Au. 2025, 5, 143-53.
87. Wang, Z. J.; Li, C. Y.; Zhao, X. Y.; Wu, Z. L.; Zheng, Q. Thermo- and photo-responsive composite hydrogels with programmed deformations. J. Mater. Chem. B. 2019, 7, 1674-8.
88. Bordbar-Khiabani, A.; Gasik, M. Smart hydrogels for advanced drug delivery systems. Int. J. Mol. Sci. 2022, 23, 3665.
89. Hu, H.; Xu, Z.; Liu, J.; et al. Light-responsive hydrogel with nano-microstructures for bacteria eradication and tumor therapy. ACS. Appl. Nano. Mater. 2025, 8, 6242-54.
90. Wang, Z.; Chen, R.; Yang, S.; Li, S.; Gao, Z. Design and application of stimuli-responsive DNA hydrogels: A review. Mater. Today. Bio. 2022, 16, 100430.
91. Aria, H.; Rezaei, M. Immunogenic cell death inducer peptides: a new approach for cancer therapy, current status and future perspectives. Biomed. Pharmacother. 2023, 161, 114503.
92. Xu, Y.; Wei, C.; Ma, L.; et al. 3D mesenchymal stem cell exosome-functionalized hydrogels for corneal wound healing. J. Control. Release. 2025, 380, 630-46.
93. Duymaz, D. Karaoğlu, İ. C.; Kizilel, S. Effect of photoinitiation process on photo-crosslinking of gelatin methacryloyl hydrogel networks. Macromol. Rapid. Commun. 2025, 46, e00376.
94. Fan, X.; Shang, H.; Ji, L.; Ma, S.; Liao, M. Preparation and biomedical application of light-responsive hydrogels based on natural products. Front. Pharmacol. 2025, 16, 1714907.
95. Kwizera, E. A.; Stewart, S.; Mahmud, M. M.; He, X. Magnetic nanoparticle-mediated heating for biomedical applications. J. Heat. Transfer. 2022, 144, 030801.
96. Kang, M. A.; Fang, J.; Paragodaarachchi, A.; et al. Magnetically induced Brownian motion of iron oxide nanocages in alternating magnetic fields and their application for efficient siRNA delivery. Nano. Lett. 2022, 22, 8852-9.
97. Li, Z.; Li, Y.; Chen, C.; Cheng, Y. Magnetic-responsive hydrogels: from strategic design to biomedical applications. J. Control. Release. 2021, 335, 541-56.
98. Suhail, M. Alamgir; Wahab, A.; et al. Magnetically responsive hydrogel systems: fundamental features, emerging applications, and future horizons. Coord. Chem. Rev. 2025, 543, 216916.
99. Gong, J.; Hu, J.; Yan, X.; et al. Injectable hydrogels including magnetic nanosheets for multidisciplinary treatment of hepatocellular carcinoma via magnetic hyperthermia. Small 2024, 20, e2300733.
100. Ma, H.; Yu, G.; Cheng, J.; et al. Design of an injectable magnetic hydrogel based on the tumor microenvironment for multimodal synergistic cancer therapy. Biomacromolecules 2023, 24, 868-85.
101. Zhou, Y.; Liu, G.; Guo, S. Advances in ultrasound-responsive hydrogels for biomedical applications. J. Mater. Chem. B. 2022, 10, 3947-58.
102. Xiao, H.; Aliabouzar, M.; Fabiilli, M. L. Acoustically responsive scaffolds: unraveling release kinetics and mechanisms for sustained, steady drug delivery. J. Control. Release. 2024, 374, 205-18.
103. Meng, Z.; Zhang, Y.; She, J.; et al. Ultrasound-mediated remotely controlled nanovaccine delivery for tumor vaccination and individualized cancer immunotherapy. Nano. Lett. 2021, 21, 1228-37.
104. Naeem, A.; Yu, C.; Zhou, L.; et al. Shape memory hydrogels in tissue engineering: Recent advances and challenges. Bioact. Mater. 2025, 54, 215-47.
105. Gerayeli, F.; Khalef, N.; Bakri, A.; Benech, P.; Martin, D. K. Ultrasound-stimulated Brownian ratchet enhances diffusion of molecules retained in hydrogels. Nanomedicine 2021, 31, 102308.
106. Huang, H.; Dong, Z.; Ren, X.; et al. High-strength hydrogels: Fabrication, reinforcement mechanisms, and applications. Nano. Res. 2023, 16, 3475-515.
107. Kang Derwent, J. J.; Mieler, W. F. Thermoresponsive hydrogels as a new ocular drug delivery platform to the posterior segment of the eye. Trans. Am. Ophthalmol. Soc. 2008, 106, 206-13.
108. Zhu, B.; Zong, T.; Zheng, R.; et al. Acid and glutathione dual-responsive, injectable and self-healing hydrogels for controlled drug delivery. Biomacromolecules 2024, 25, 1838-49.
109. Zhang, Q.; Yan, K.; Zheng, X.; Liu, Q.; Han, Y.; Liu, Z. Research progress of photo-crosslink hydrogels in ophthalmology: a comprehensive review focus on the applications. Mater. Today. Bio. 2024, 26, 101082.
110. Abdelmohsen, H. A. M.; Copeland, N. A.; Hardy, J. G. Light-responsive biomaterials for ocular drug delivery. Drug. Deliv. Transl. Res. 2023, 13, 2159-82.
111. Yan, L.; Zhao, Z.; Liu, Y.; et al. The inverse electron demand Diels-alder (IEDDA): a facile bioorthogonal click reaction for development of injectable polysaccharide-based hydrogels for biomedical applications. Carbohydr. Polym. 2025, 352, 123142.
112. Morozova, S. M. Recent advances in hydrogels via Diels-alder crosslinking: design and applications. Gels 2023, 9, 102.
113. Sojdeh, S.; Panjipour, A.; Yaghmour, A.; Arabpour, Z.; Djalilian, A. R. Click chemistry-based hydrogels for tissue engineering. Gels 2025, 11, 724.
114. Guo, Z.; Xiu, L.; Li, Y.; et al. Injectable nanocomposite hydrogel with cascade drug release for treatment of uveal melanoma. J. Control. Release. 2024, 376, 1086-99.
115. Ali, I.; Gulfam, M.; Jo, S. H.; et al. Reduction-responsive and bioorthogonal carboxymethyl cellulose based soft hydrogels cross-linked via IEDDA click chemistry for cancer therapy application. Int. J. Biol. Macromol. 2022, 219, 109-20.
116. Ilochonwu, B. C.; van der Lugt, S. A.; Annala, A.; et al. Thermo-responsive Diels-Alder stabilized hydrogels for ocular drug delivery of a corticosteroid and an anti-VEGF fab fragment. J. Control. Release. 2023, 361, 334-49.
117. Yang, J.; Chen, Y.; Zhao, L.; Zhang, J.; Luo, H. Constructions and properties of physically cross-linked hydrogels based on natural polymers. Polym. Rev. 2022, 63, 574-612.
118. Zhang, T.; Ping, W.; Suo, M.; et al. Stimuli-responsive hydrogels potentiating photothermal therapy against cancer stem cell-induced breast cancer metastasis. ACS. Nano. 2024, 18, 20313-23.
119. Wu, Y.; Chang, X.; Yang, G.; et al. A physiologically responsive nanocomposite hydrogel for treatment of head and neck squamous cell carcinoma via proteolysis-targeting chimeras enhanced immunotherapy. Adv. Mater. 2023, 35, e2210787.
120. Liu, W. S.; Lu, Z. M.; Pu, X. H.; et al. A dendritic cell-recruiting, antimicrobial blood clot hydrogel for melanoma recurrence prevention and infected wound management. Biomaterials 2025, 313, 122776.
121. Gong, Y.; Yuan, W.; Liu, S.; et al. Physical encapsulation and chemotherapy: a synergistic hydrogel strategy for tumor suppression. Adv. Healthc. Mater. 2025, 14, e2500511.
122. Guan, T.; Chen, Z.; Wang, X.; et al. Harnessing Mn2+ ions and antitumor peptides: a robust hydrogel for enhanced tumor immunotherapy. J. Am. Chem. Soc. 2025, 147, 6523-35.
123. Raza, M. A.; Lim, Y. M.; Lee, S. W.; Seralathan, K. K.; Park, S. H. Synthesis and characterization of hydrogels based on carboxymethyl chitosan and poly(vinylpyrrolidone) blends prepared by electron beam irradiation having anticancer efficacy, and applications as drug carrier for controlled release of drug. Carbohydr. Polym. 2021, 258, 117718.
124. Elshahawy, M. F.; Mohamed, R. D.; Ali, A. E.; Raafat, A. I.; Ahmed, N. A. Electron beam irradiation developed cinnamon oil- (polyvinyl alcohol/gum tragacanth)/graphene oxide dressing hydrogels: antimicrobial and healing assessments. Int. J. Biol. Macromol. 2024, 277, 134384.
125. Cheng, Y. H.; Huang, H. P.; Chen, H. H. Mucoadhesive phenylboronic acid-grafted carboxymethyl cellulose hydrogels containing glutathione for treatment of corneal epithelial cells exposed to benzalkonium chloride. Colloids. Surf. B. Biointerfaces. 2024, 238, 113884.
126. Devi V K, A.; Shyam, R.; Palaniappan, A.; Jaiswal, A. K.; Oh, T. H.; Nathanael, A. J. Self-healing hydrogels: preparation, mechanism and advancement in biomedical applications. Polymers. (Basel). 2021, 13, 3782.
127. Duan, Y.; Ding, L.; Meng, X.; et al. A therapeutic strategy integrating ultrasound-guided microwave ablation with nanocomposite hydrogels to enhance autophagy and suppress tumor growth in hepatocellular carcinoma. Acta. Biomater. 2025, 198, 413-27.
128. Annala, A.; Ilochonwu, B. C.; Wilbie, D.; Sadeghi, A.; Hennink, W. E.; Vermonden, T. Self-healing thermosensitive hydrogel for sustained release of dexamethasone for ocular therapy. ACS. Polym. Au. 2023, 3, 118-31.
129. Stevanović, M.; Jović, M.; Filipović, N.; et al. Multifunctional nanomaterial-integrated hydrogels for sustained drug delivery: from synthesis and characterization to biomedical application. Gels 2025, 11, 892.
130. Li, Z.; Yang, L.; Zhang, D.; et al. Mussel-inspired “plug-and-play” hydrogel glue for postoperative tumor recurrence and wound infection inhibition. J. Colloid. Interface. Sci. 2023, 650, 1907-17.
131. Ge, J.; Caldona, E. B.; Advincula, R. C. Functional stimuli-responsive polymers on micro- and nano-patterned interfaces. Polymer 2025, 317, 127958.
132. Wang, X.; Wang, Q. Enzyme-laden bioactive hydrogel for biocatalytic monitoring and regulation. Acc. Chem. Res. 2021, 54, 1274-87.
133. Yin, W.; Ke, W.; Lu, N.; et al. Glutathione and reactive oxygen species dual-responsive block copolymer prodrugs for boosting tumor site-specific drug release and enhanced antitumor efficacy. Biomacromolecules 2020, 21, 921-9.
134. Wang, L.; Ye, C.; Xue, X.; et al. 3D-printed breast prosthesis that smartly senses and targets breast cancer relapse. Adv. Sci. (Weinh). 2024, 11, e2402345.
135. Prince, E.; Cruickshank, J.; Ba-Alawi, W.; et al. Biomimetic hydrogel supports initiation and growth of patient-derived breast tumor organoids. Nat. Commun. 2022, 13, 1466.
136. Xu, Z.; Liu, L.; Duan, J.; et al. A host/guest assembled hyaluronic acid-based supramolecular hydrogel with NIR-steered degradation capacity for enhanced tumor therapy through programmable drug release. Carbohydr. Polym. 2025, 368, 124098.
137. Liang, X.; Li, X.; Wu, R.; et al. Breaking the tumor chronic inflammation balance with a programmable release and multi-stimulation engineering scaffold for potent immunotherapy. Adv. Sci. (Weinh). 2024, 11, e2401377.
138. Luo, F. Q.; Xu, W.; Zhang, J. Y.; et al. An injectable nanocomposite hydrogel improves tumor penetration and cancer treatment efficacy. Acta. Biomater. 2022, 147, 235-44.
139. Peppas, N. A.; Merrill, E. W. Crosslinked poly(vinyl alcohol) hydrogels as swollen elastic networks. J. Appl. Polym. Sci. 2003, 21, 1763-70.
140. Ilochonwu, B. C.; Urtti, A.; Hennink, W. E.; Vermonden, T. Intravitreal hydrogels for sustained release of therapeutic proteins. J. Control. Release. 2020, 326, 419-41.
141. Chang, D.; Park, K.; Famili, A. Hydrogels for sustained delivery of biologics to the back of the eye. Drug. Discov. Today. 2019, 24, 1470-82.
142. Richbourg, N. R.; Peppas, N. A. The swollen polymer network hypothesis: quantitative models of hydrogel swelling, stiffness, and solute transport. Prog. Polym. Sci. 2020, 105, 101243.
143. Li, J.; Mooney, D. J. Designing hydrogels for controlled drug delivery. Nat. Rev. Mater. 2016, 1, 1-17.
144. Campbell, K. T.; Wysoczynski, K.; Hadley, D. J.; Silva, E. A. Computational-based design of hydrogels with predictable mesh properties. ACS. Biomater. Sci. Eng. 2020, 6, 308-19.
145. Shirakura, T.; Smith, C.; Hopkins, T. J. J.; et al. Matrix density engineering of hydrogel nanoparticles with simulation-guided synthesis for tuning drug release and cellular uptake. ACS. Omega. 2017, 2, 3380-9.
146. Tram, N. K.; Maxwell, C. J.; Swindle-Reilly, K. E. Macro- and microscale properties of the vitreous humor to inform substitute design and intravitreal biotransport. Curr. Eye. Res. 2021, 46, 429-44.
147. Cooper, R. C.; Wang, J.; Yang, H. Injectable dendrimer hydrogel delivers melphalan in both conjugated and free forms for retinoblastoma. Biomacromolecules 2024, 25, 5928-37.
148. Huo, Y.; Wang, Q.; Liu, Y.; et al. A temperature-sensitive phase-change hydrogel of topotecan achieves a long-term sustained antitumor effect on retinoblastoma cells. Onco. Targets. Ther. 2019, 12, 6069-82.
149. Xie, L.; Yue, W.; Ibrahim, K.; Shen, J. A long-acting curcumin nanoparticle/in situ hydrogel composite for the treatment of uveal melanoma. Pharmaceutics 2021, 13, 1335.
150. Li, L.; Zeng, Z.; Chen, Z.; et al. Microenvironment-triggered degradable hydrogel for imaging diagnosis and combined treatment of intraocular choroidal melanoma. ACS. Nano. 2020, 14, 15403-16.
151. Kim, D. I.; Lee, H.; Kwon, S. H.; Sung, Y. J.; Song, W. K.; Park, S. Bilayer hydrogel sheet-type intraocular microrobot for drug delivery and magnetic nanoparticles retrieval. Adv. Healthc. Mater. 2020, 9, e2000118.
152. Taich, P.; Moretton, M. A.; Del Sole, M. J.; et al. Sustained-release hydrogels of topotecan for retinoblastoma. Colloids. Surf. B. Biointerfaces. 2016, 146, 624-31.
153. Cocarta, A. I.; Hobzova, R.; Sirc, J.; et al. Hydrogel implants for transscleral drug delivery for retinoblastoma treatment. Mater. Sci. Eng. C. Mater. Biol. Appl. 2019, 103, 109799.
154. Hobzova, R.; Kodetova, M.; Pochop, P.; et al. Hydrogel implants for transscleral diffusion delivery of topotecan: In vivo proof of concept in a rabbit eye model. Int. J. Pharm. 2021, 606, 120832.
155. Chen, M.; Hu, J.; Gao, H.; et al. An immunotherapeutic artificial vitreous body hydrogel to control choroidal melanoma and preserve vision after vitrectomy. Sci. Adv. 2023, 9, eadh1582.
156. Lin, Y.; Luo, W.; Jiang, B.; et al. The effect of GelDex-S58 hydrogel on anti-conjunctival scarring after glaucoma filtration surgery. iScience 2023, 26, 107633.
157. Wang, C.; Wang, J.; Zhang, X.; et al. In situ formed reactive oxygen species-responsive scaffold with gemcitabine and checkpoint inhibitor for combination therapy. Sci. Transl. Med. 2018, 10, eaan3682.
158. Song, H.; Su, Q.; Nie, Y.; et al. Supramolecular assembly of a trivalent peptide hydrogel vaccine for cancer immunotherapy. Acta. Biomater. 2023, 158, 535-46.
160. Wang, K.; Chen, Y.; Ahn, S.; et al. GD2-specific CAR T cells encapsulated in an injectable hydrogel control retinoblastoma and preserve vision. Nat. Cancer. 2020, 1, 990-7.
161. Wang, G.; Wu, K.; Zhang, Z.; et al. Injectable hydrogel-mediated co-delivery of oncolytic adenovirus and melphalan for retinoblastoma control and vision preservation. Acta. Pharm. Sin. B. 2025, 15, 6638-56.
162. Yang, M.; Huang, Y.; Chen, Z.; et al. Synthetic carbon-based lanthanide upconversion nanoparticles for enhanced photothermal therapy. Nat. Commun. 2025, 16, 6343.
163. Lin, M.; Liu, X.; Li, J.; et al. Hybrid NIR-responsive liposome/hydrogel platform mediating chemo-photothermal therapy of retinoblastoma enhanced by quercetin as an adjuvant. Theranostics 2025, 15, 3995-4015.
164. Wang, S.; Chen, B.; Ouyang, L.; et al. A novel stimuli-responsive injectable antibacterial hydrogel to achieve synergetic photothermal/gene-targeted therapy towards uveal melanoma. Adv. Sci. (Weinh). 2021, 8, e2004721.
165. Xie, P.; He, J.; Ou, Y. Metal complex hydrogel as a dual functional photothermal platform for in vitro doxorubicin delivery in ocular melanoma treatment. Polym. Adv. Technol. 2025, 36, e70136.
166. Jager, M. J.; Shields, C. L.; Cebulla, C. M.; et al. Uveal melanoma. Nat. Rev. Dis. Primers. 2020, 6, 24.
167. Chiang, B.; Jung, J. H.; Prausnitz, M. R. The suprachoroidal space as a route of administration to the posterior segment of the eye. Adv. Drug. Delivery. Rev. 2018, 126, 58-66.
168. Wu, K. Y.; Fujioka, J. K.; Gholamian, T.; Zaharia, M.; Tran, S. D. Suprachoroidal injection: a novel approach for targeted drug delivery. Pharmaceuticals. (Basel). 2023, 16, 1241.
169. Ghassemi, F.; Shields, C. L.; Ghadimi, H.; Khodabandeh, A.; Roohipoor, R. Combined intravitreal melphalan and topotecan for refractory or recurrent vitreous seeding from retinoblastoma. JAMA. Ophthalmol. 2014, 132, 936-41.
170. Riazi-Esfahani, H.; Masoomian, B.; Khodabandeh, A.; et al. Addition of intravitreal carboplatin with melphalan for management of vitreous seeding in retinoblastoma. Graefes. Arch. Clin. Exp. Ophthalmol. 2023, 261, 1167-75.
171. Galardi, A.; Colletti, M.; Lavarello, C.; et al. Proteomic profiling of retinoblastoma-derived exosomes reveals potential biomarkers of vitreous seeding. Cancers. (Basel). 2020, 12, 1555.
172. Andreucci, E.; Peppicelli, S.; Ruzzolini, J.; et al. The acidic tumor microenvironment drives a stem-like phenotype in melanoma cells. J. Mol. Med. (Berl). 2020, 98, 1431-46.
173. Wang, T.; Zhang, Y.; Bai, J.; Xue, Y.; Peng, Q. MMP1 and MMP9 are potential prognostic biomarkers and targets for uveal melanoma. BMC. Cancer. 2021, 21, 1068.
174. Sudhakar, J.; Venkatesan, N.; Lakshmanan, S.; Khetan, V.; Krishnakumar, S.; Biswas, J. Hypoxic tumor microenvironment in advanced retinoblastoma. Pediatr. Blood. Cancer. 2013, 60, 1598-601.
175. Sradhanjali, S.; Tripathy, D.; Rath, S.; Mittal, R.; Reddy, M. M. Overexpression of pyruvate dehydrogenase kinase 1 in retinoblastoma: a potential therapeutic opportunity for targeting vitreous seeds and hypoxic regions. PLoS. ONE. 2017, 12, e0177744.
176. Miracco, C.; Toti, P.; Gelmi, M. C.; et al. Retinoblastoma is characterized by a cold, CD8+ cell poor, PD-L1- microenvironment, which turns into hot, CD8+ cell rich, PD-L1+ after chemotherapy. Invest. Ophthalmol. Vis. Sci. 2021, 62, 6.
177. Bai, H.; Bosch, J. J.; Heindl, L. M. Current management of uveal melanoma: a review. Clin. Exp. Ophthalmol. 2023, 51, 484-94.
178. Hu, J.; Liu, X.; Gao, Q.; Ouyang, C.; Zheng, K.; Shan, X. Thermosensitive PNIPAM-based hydrogel crosslinked by composite nanoparticles as rapid wound-healing dressings. Biomacromolecules 2023, 24, 1345-54.
179. Wu, K. Y.; Wang, X. C.; Anderson, M.; Tran, S. D. Advancements in nanosystems for ocular drug delivery: a focus on pediatric retinoblastoma. Molecules 2024, 29, 2263.
180. Wang, T.; Ran, R.; Ma, Y.; Zhang, M. Polymeric hydrogel as a vitreous substitute: current research, challenges, and future directions. Biomed. Mater. 2021, 16, 042012.
181. Lin, Q.; Lim, J. Y. C.; Xue, K.; Su, X.; Loh, X. J. Polymeric hydrogels as a vitreous replacement strategy in the eye. Biomaterials 2021, 268, 120547.
182. Huibers, A.; Wong, A.; Burgmans, M.; et al. Management of liver metastases from uveal melanoma. Br. J. Surg. 2025, 112, znaf130.
183. Farhat, W.; Yeung, V.; Ross, A.; et al. Advances in biomaterials for the treatment of retinoblastoma. Biomater. Sci. 2022, 10, 5391-429.
184. Zang, C.; Tian, Y.; Tang, Y.; et al. Hydrogel-based platforms for site-specific doxorubicin release in cancer therapy. J. Transl. Med. 2024, 22, 879.
185. Elsawy, M. A.; Wychowaniec, J. K.; Castillo Díaz, L. A.; Smith, A. M.; Miller, A. F.; Saiani, A. Controlling doxorubicin release from a peptide hydrogel through fine-tuning of drug-peptide fiber interactions. Biomacromolecules 2022, 23, 2624-34.
186. Qu, S.; Tang, Y.; Ning, Z.; Zhou, Y.; Wu, H. Desired properties of polymeric hydrogel vitreous substitute. Biomed. Pharmacother. 2024, 172, 116154.
187. Chan, K. C.; Yu, Y.; Ng, S. H.; et al. Intracameral injection of a chemically cross-linked hydrogel to study chronic neurodegeneration in glaucoma. Acta. Biomater. 2019, 94, 219-31.
188. Booler, H.; Larsen, T.; Shelton, A.; Bansteev, V.; Mitra, M. S. Foreign body reaction, retinal degeneration, and epiretinal membranes associated with intravitreal administration of PLGA rods. Toxicol. Pathol. 2021, 49, 656-62.
